平和 伸仁 ひらわ のぶひと 先生

来歴等

略歴

1987年 横浜市立大学医学部医学科 卒業
1991年 横浜市立大学大学院医学研究科　内科学第二講座　 修了　医学博士取得
1991年 NTT関東逓信病院　腎臓内科
1998年 東京大学 非常勤講師
1999年 横浜市立大学附属病院 助手
2002年 横浜市立大学 学内講師、医局長
2004年 横浜市立大学附属市民総合医療センター 助教授（准教授）
2008年 横浜市立大学附属市民総合医療センター　血液浄化療法部 部長
2012年 横浜市立大学附属市民総合医療センター 臨床教育研修センター長　兼務
2018年 横浜市立大学附属市民総合医療センター　腎臓・高血圧内科 部長

論文

• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019), Hypertens Res. 2019 Sep;42(9):1235-1481. doi: 10.1038/s41440-019-0284-9.

  Umemura, S. Arima, H. Arima, S. Asayama, K. Dohi, Y. Hirooka, Y. Horio, T. Hoshide, S. Ikeda, S. Ishimitsu, T. Ito, M. Ito, S. Iwashima, Y. Kai, H. Kamide, K. Kanno, Y. Kashihara, N. Kawano, Y. Kikuchi, T. Kitamura, K. Kitazono, T. Kohara, K. Kudo, M. Kumagai, H. Matsumura, K. Matsuura, H. Miura, K. Mukoyama, M. Nakamura, S. Ohkubo, T. Ohya, Y. Okura, T. Rakugi, H. Saitoh, S. Shibata, H. Shimosawa, T. Suzuki, H. Takahashi, S. Tamura, K. Tomiyama, H. Tsuchihashi, T. Ueda, S. Uehara, Y. Urata, H. Hirawa, N.

• Viewpoint on Guidelines for Treatment of Hypertension in Japan, Circ Res. 2019 Mar 29;124(7):981-983. doi: 10.1161/CIRCRESAHA.119.314991.

  Hirawa, N. Umemura, S. Ito, S.

• Reduced secretion of parathyroid hormone and hypocalcemia in systemic heterozygous ATP2B1-null hypertensive mice, Hypertens Res. 2018 Sep;41(9):699-707. doi: 10.1038/s41440-018-0067-8. Epub 2018 Jun 27.

  Ehara, Y. Hirawa, N. Sumida, K. Fujiwara, A. Kagimoto, M. Ooki-Okuyama, Y. Fujita, M. Katsumata, M. Kobayashi, Y. Saka, S. Katou, I. Yatsu, K. Umemura, S. Tamura, K.

• Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure, Clin Exp Nephrol. 2017 Oct;21(5):858-865. doi: 10.1007/s10157-016-1379-0. Epub 2017 Feb 11.

  Katsumata, M. Hirawa, N. Sumida, K. Kagimoto, M. Ehara, Y. Okuyama, Y. Fujita, M. Fujiwara, A. Kobayashi, M. Kobayashi, Y. Yamamoto, Y. Saka, S. Yatsu, K. Fujikawa, T. Toya, Y. Yasuda, G. Tamura, K. Umemura, S.

• Relation between circadian blood pressure rhythm and serum albumin level in non-diabetic patients with proteinuria, Blood Press. 2016 Feb;25(1):44-50. doi: 10.3109/08037051.2016.1095916. Epub 2015 Oct 14.

  Ando, D. Hirawa, N. Yasuda, G.

• Effects of doxazosin as the third agent on morning hypertension and position-related blood pressure changes in diabetic patients with chronic kidney disease, Clin Exp Hypertens. 2015;37(1):75-81. doi: 10.3109/10641963.2014.913599. Epub 2014 May 27.

  Yasuda, G. Saka, S. Ando, D. Hirawa, N.

• Genome-wide association study of IgA nephropathy using 23 465 microsatellite markers in a Japanese population, J Hum Genet. 2015 Oct;60(10):573-80. doi: 10.1038/jhg.2015.88. Epub 2015 Jul 23.

  Saka, S. Hirawa, N. Oka, A. Yatsu, K. Hirukawa, T. Yamamoto, R. Matsusaka, T. Imai, E. Narita, I. Endoh, M. Ichikawa, I. Umemura, S. Inoko, H.

• Efficacy of cyclosporine combination therapy for new-onset minimal change nephrotic syndrome in adults, Clin Exp Nephrol. 2015 Apr;19(2):240-6. doi: 10.1007/s10157-014-0975-0. Epub 2014 Apr 27.

  Fujiwara, A. Hirawa, N. Kobayashi, Y. Yatsu, K. Katsumata, M. Ehara, Y. Okuyama, Y. Yutoh, J. Kaneda, T. Fujita, M. Yamamoto, Y. Saka, S. Toya, Y. Yasuda, G. Umemura, S.

• Efficacy of cyclosporine conset minimal change nephrotic syndrome in adultsombination therapy for new-, Clin Exp Nephrol. 2015 Apr;19(2):240-6. doi: 10.1007/s10157-014-0975-0. Epub 2014 Apr 27.

  Fujiwara, A. Hirawa, N. Kobayashi, Y. Yatsu, K. Katsumata, M. Ehara, Y. Okuyama, Y. Yutoh, J. Kaneda, T. Fujita, M. Yamamoto, Y. Saka, S. Toya, Y. Yasuda, G. Umemura, S.

• Impaired nitric oxide production and increased blood pressure in systemic heterozygous ATP2B1 null mice, J Hypertens. 2014 Jul;32(7):1415-23; discussion 1423. doi: 10.1097/HJH.0000000000000206.

  Fujiwara, A. Hirawa, N. Fujita, M. Kobayashi, Y. Okuyama, Y. Yatsu, K. Katsumata, M. Yamamoto, Y. Ichihara, N. Saka, S. Toya, Y. Yasuda, G. Goshima, Y. Tabara, Y. Miki, T. Ueshima, H. Ishikawa, Y. Umemura, S.

• ATP2B1 and blood pressure: from associations to pathophysiology, Curr Opin Nephrol Hypertens. 2013 Mar;22(2):177-84. doi: 10.1097/MNH.0b013e32835da4ca.

  Hirawa, N. Fujiwara, A. Umemura, S.

• Effects of Carvedilol as Third-Line Add-On Therapy on Blood Pressure and Glucose Metabolism in Type 2 Diabetic Patients with Chronic Renal Disease Stage 3 and Above, Kidney Blood Press Res. 2012 Oct 23;36(1):131-138.

  Yasuda, G. Yatsu, K. Yamamoto, Y. Hirawa, N.

• Mice Lacking Hypertension Candidate Gene ATP2B1 in Vascular Smooth Muscle Cells Show Significant Blood Pressure Elevation, Hypertension. 2012 Apr;59(4):854-60. Epub 2012 Feb 6.

  Kobayashi, Y. Hirawa, N. Tabara, Y. Muraoka, H. Fujita, M. Miyazaki, N. Fujiwara, A. Ichikawa, Y. Yamamoto, Y. Ichihara, N. Saka, S. Wakui, H. Yoshida, S. Yatsu, K. Toya, Y. Yasuda, G. Kohara, K. Kita, Y. Takei, K. Goshima, Y. Ishikawa, Y. Ueshima, H. Miki, T. Umemura, S.

• Long-Term Efficacy and Safety of the Small-Sized beta2-Microglobulin Adsorption Column for Dialysis-Related Amyloidosis, Ther Apher Dial. 2011 Oct;15(5):466-474. doi: 10.1111/j.1744-9987.2011.00937.x. Epub 2011 May 25.

  Yamamoto, Y. Hirawa, N. Yamaguchi, S. Ogawa, N. Takeda, H. Shibuya, K. Kawahara, K. Kojima, H. Dobashi, Y. Fujita, M. Azusima, K. Miyazaki, N. Kobayashi, M. Kobayashi, C. Fujiwara, A. Yuto, J. Saka, S. Yatsu, K. Toya, Y. Yasuda, G. Ohnishi, T. Umemura, S.

• Silent brain infarction and rapid decline of kidney function in patients with CKD: a prospective cohort study, Am J Kidney Dis. 2010 Sep;56(3):468-76.

  Kobayashi, M. Hirawa, N. Morita, S. Yatsu, K. Kobayashi, Y. Yamamoto, Y. Saka, S. Toya, Y. Yasuda, G. Umemura, S.

著書

• 【共著】高血圧治療ガイドライン2019　ライフサイエンス出版　東京